These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


312 related items for PubMed ID: 10886563

  • 21. Urine epidermal growth factor, monocyte chemoattractant protein-1 or their ratio as predictors of complete remission in primary glomerulonephritis.
    Chanrat E, Worawichawong S, Radinahamed P, Sathirapongsasuti N, Nongnuch A, Assanatham M, Udomsubpayakul U, Kitiyakara C.
    Cytokine; 2018 Apr; 104():1-7. PubMed ID: 29414320
    [Abstract] [Full Text] [Related]

  • 22. Urinary EGF and MCP-1 and risk of CKD after cardiac surgery.
    Menez S, Ju W, Menon R, Moledina DG, Thiessen Philbrook H, McArthur E, Jia Y, Obeid W, Mansour SG, Koyner JL, Shlipak MG, Coca SG, Garg AX, Bomback AS, Kellum JA, Kretzler M, Parikh CR, Translational Research Investigating Biomarker Endpoints in AKI (TRIBE-AKI) Consortium and the Kidney Precision Medicine Project.
    JCI Insight; 2021 Jun 08; 6(11):. PubMed ID: 33974569
    [Abstract] [Full Text] [Related]

  • 23. Urinary concentration and tissue messenger RNA expression of monocyte chemoattractant protein-1 as an indicator of the degree of hydronephrotic atrophy in partial ureteral obstruction.
    Stephan M, Conrad S, Eggert T, Heuer R, Fernandez S, Huland H.
    J Urol; 2002 Mar 08; 167(3):1497-502. PubMed ID: 11832777
    [Abstract] [Full Text] [Related]

  • 24. Urinary cytokine profiles in unilateral congenital hydronephrosis.
    Taranta-Janusz K, Wasilewska A, Dębek W, Waszkiewicz-Stojda M.
    Pediatr Nephrol; 2012 Nov 08; 27(11):2107-2113. PubMed ID: 22744767
    [Abstract] [Full Text] [Related]

  • 25. Increased urinary excretion of monocyte chemoattractant protein-1 during acute renal allograft rejection.
    Prodjosudjadi W, Daha MR, Gerritsma JS, Florijn KW, Barendregt JN, Bruijn JA, van der Woude FJ, van Es LA.
    Nephrol Dial Transplant; 1996 Jun 08; 11(6):1096-103. PubMed ID: 8671975
    [Abstract] [Full Text] [Related]

  • 26. Urinary angiotensinogen as a novel marker of obstructive nephropathy in children.
    Taranta-Janusz K, Wasilewska A, Dębek W, Fiłonowicz R, Michaluk-Skutnik J.
    Acta Paediatr; 2013 Sep 08; 102(9):e429-33. PubMed ID: 23772991
    [Abstract] [Full Text] [Related]

  • 27. Value of urinary levels of interleukin-6, epidermal growth factor, monocyte chemoattractant protein type1 and transforming growth factor β1 in predicting the extent of fibrosis lesions in kidney biopsies of patients with IgA nephropathy.
    Segarra-Medrano A, Carnicer-Caceres C, Valtierra-Carmeno N, Agraz-Pamplona I, Ramos-Terrades N, Jatem Escalante E, Ostos-Roldan E.
    Nefrologia; 2017 Sep 08; 37(5):531-538. PubMed ID: 28946966
    [Abstract] [Full Text] [Related]

  • 28. Prediction of the outcome of antenatal hydronephrosis: significance of urinary EGF.
    Li Z, Zhao Z, Liu X, Su Z, Shang X, Wen J.
    Pediatr Nephrol; 2012 Dec 08; 27(12):2251-9. PubMed ID: 22773267
    [Abstract] [Full Text] [Related]

  • 29. Congenital ureteropelvic junction obstruction: physiopathology, decoupling of tout court pelvic dilatation-obstruction semantic connection, biomarkers to predict renal damage evolution.
    Alberti C.
    Eur Rev Med Pharmacol Sci; 2012 Feb 08; 16(2):213-9. PubMed ID: 22428472
    [Abstract] [Full Text] [Related]

  • 30. Expression of chemokine and fibrosing factor messenger RNA in the urinary sediment of patients with lupus nephritis.
    Chan RW, Lai FM, Li EK, Tam LS, Wong TY, Szeto CY, Li PK, Szeto CC.
    Arthritis Rheum; 2004 Sep 08; 50(9):2882-90. PubMed ID: 15457456
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Urinary and serum carbohydrate antigen 19-9 as a biomarker in ureteropelvic junction obstruction in children.
    Kajbafzadeh AM, Elmi A, Talab SS, Emami H, Esfahani SA, Saeedi P.
    J Urol; 2010 Jun 08; 183(6):2353-60. PubMed ID: 20400153
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Urinary antimicrobial peptides: Potential novel biomarkers of obstructive uropathy.
    Gupta S, Jackson AR, DaJusta DG, McLeod DJ, Alpert SA, Jayanthi VR, McHugh K, Schwaderer AR, Becknell B, Ching CB.
    J Pediatr Urol; 2018 Jun 08; 14(3):238.e1-238.e6. PubMed ID: 29706289
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Monocyte recruitment in cryoglobulinemic membranoproliferative glomerulonephritis: a pathogenetic role for monocyte chemotactic peptide-1.
    Gesualdo L, Grandaliano G, Ranieri E, Monno R, Montinaro V, Manno C, Schena FP.
    Kidney Int; 1997 Jan 08; 51(1):155-63. PubMed ID: 8995729
    [Abstract] [Full Text] [Related]

  • 40. Immunocytological urinalysis and monocyte chemotactic peptide-1 in renal transplant recipients with polyomavirus replication.
    Boratyńska M, Dubiński B, Rybka K, Jezior D, Szyber P, Klinger M.
    Transplant Proc; 2006 Jan 08; 38(1):151-4. PubMed ID: 16504689
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 16.